ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,404,000 | -91.3% | 50,000 | -92.0% | 0.01% | -89.1% |
| Q4 2020 | $16,225,000 | +51.5% | 625,000 | 0.0% | 0.13% | +59.3% |
| Q3 2020 | $10,713,000 | -30.7% | 625,000 | 0.0% | 0.08% | -42.6% |
| Q2 2020 | $15,463,000 | +45.2% | 625,000 | -18.5% | 0.14% | -2.1% |
| Q1 2020 | $10,648,000 | +37.4% | 767,128 | 0.0% | 0.14% | +48.5% |
| Q4 2019 | $7,748,000 | +11.0% | 767,128 | 0.0% | 0.10% | +1.0% |
| Q3 2019 | $6,981,000 | +106.6% | 767,128 | +80.5% | 0.10% | +26.3% |
| Q2 2019 | $3,379,000 | -36.3% | 425,000 | 0.0% | 0.08% | -48.6% |
| Q1 2019 | $5,308,000 | +16.0% | 425,000 | 0.0% | 0.15% | -22.1% |
| Q4 2018 | $4,577,000 | – | 425,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |